99 related articles for article (PubMed ID: 28032865)
21. TIMP3 Overexpression Improves the Sensitivity of Osteosarcoma to Cisplatin by Reducing IL-6 Production.
Han XG; Mo HM; Liu XQ; Li Y; Du L; Qiao H; Fan QM; Zhao J; Zhang SH; Tang TT
Front Genet; 2018; 9():135. PubMed ID: 29731768
[TBL] [Abstract][Full Text] [Related]
22. miR-223-3p Inhibits Human Osteosarcoma Metastasis and Progression by Directly Targeting CDH6.
Ji Q; Xu X; Song Q; Xu Y; Tai Y; Goodman SB; Bi W; Xu M; Jiao S; Maloney WJ; Wang Y
Mol Ther; 2018 May; 26(5):1299-1312. PubMed ID: 29628305
[TBL] [Abstract][Full Text] [Related]
23. Neuroprotective Drug for Nerve Trauma Revealed Using Artificial Intelligence.
Romeo-Guitart D; Forés J; Herrando-Grabulosa M; Valls R; Leiva-Rodríguez T; Galea E; González-Pérez F; Navarro X; Petegnief V; Bosch A; Coma M; Mas JM; Casas C
Sci Rep; 2018 Jan; 8(1):1879. PubMed ID: 29382857
[TBL] [Abstract][Full Text] [Related]
24. Scorpins in the DNA Damage Response.
Palmieri D; Tessari A; Coppola V
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29914204
[TBL] [Abstract][Full Text] [Related]
25. Cell signalling pathway regulation by RanBPM: molecular insights and disease implications.
Salemi LM; Maitland MER; McTavish CJ; Schild-Poulter C
Open Biol; 2017 Jun; 7(6):. PubMed ID: 28659384
[TBL] [Abstract][Full Text] [Related]
26. RanBP9/TSSC3 complex cooperates to suppress anoikis resistance and metastasis via inhibiting Src-mediated Akt signaling in osteosarcoma.
Dai H; Lv YF; Yan GN; Meng G; Zhang X; Guo QN
Cell Death Dis; 2016 Dec; 7(12):e2572. PubMed ID: 28032865
[TBL] [Abstract][Full Text] [Related]
27. TSSC3 promotes autophagy via inactivating the Src-mediated PI3K/Akt/mTOR pathway to suppress tumorigenesis and metastasis in osteosarcoma, and predicts a favorable prognosis.
Zhao GS; Gao ZR; Zhang Q; Tang XF; Lv YF; Zhang ZS; Zhang Y; Tan QL; Peng DB; Jiang DM; Guo QN
J Exp Clin Cancer Res; 2018 Aug; 37(1):188. PubMed ID: 30092789
[TBL] [Abstract][Full Text] [Related]
28. Tumor-Suppressing STF cDNA 3 Overexpression Suppresses Renal Fibrosis by Alleviating Anoikis Resistance and Inhibiting the PI3K/Akt Pathway.
Xiao F; Liu X; Chen Y; Dai H
Kidney Blood Press Res; 2021; 46(5):588-600. PubMed ID: 34284400
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of tumor suppressing STF cDNA 3 promotes epithelial-mesenchymal transition and tumor metastasis of osteosarcoma by the Wnt/GSK-3β/β-catenin/Snail signaling pathway.
Lv YF; Dai H; Yan GN; Meng G; Zhang X; Guo QN
Cancer Lett; 2016 Apr; 373(2):164-73. PubMed ID: 26845447
[TBL] [Abstract][Full Text] [Related]
30. MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway.
Dong Y; Liang G; Yuan B; Yang C; Gao R; Zhou X
Tumour Biol; 2015 Mar; 36(3):1477-86. PubMed ID: 25431257
[TBL] [Abstract][Full Text] [Related]
31. TSSC3 represses self-renewal of osteosarcoma stem cells and Nanog expression by inhibiting the Src/Akt pathway.
Yan GN; Tang XF; Zhang XC; He T; Huang YS; Zhang X; Meng G; Guo DY; Lv YF; Guo QN
Oncotarget; 2017 Oct; 8(49):85628-85641. PubMed ID: 29156746
[TBL] [Abstract][Full Text] [Related]
32. Enhancer of zeste homolog 2 silencing inhibits tumor growth and lung metastasis in osteosarcoma.
Lv YF; Yan GN; Meng G; Zhang X; Guo QN
Sci Rep; 2015 Aug; 5():12999. PubMed ID: 26265454
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic silencing of methyl-CpG-binding protein 2 gene affects proliferation, invasion, migration, and apoptosis of human osteosarcoma cells.
Meng G; Lv Y; Dai H; Zhang X; Guo QN
Tumour Biol; 2014 Dec; 35(12):11819-27. PubMed ID: 25227661
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic regulation of the pro-apoptosis gene TSSC3 in human osteosarcoma cells.
Li Y; Huang Y; Lv Y; Meng G; Guo QN
Biomed Pharmacother; 2014 Feb; 68(1):45-50. PubMed ID: 24268429
[TBL] [Abstract][Full Text] [Related]
35. Anoikis molecular pathways and its role in cancer progression.
Paoli P; Giannoni E; Chiarugi P
Biochim Biophys Acta; 2013 Dec; 1833(12):3481-3498. PubMed ID: 23830918
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
